Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Coen

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Investigative Dermatology|July 1, 1984
Genetics of herpes simplex virusP A Schaffer, S K Weller, B A Pancake, et al.
Nucleic Acids Research|March 11, 1990
Enzymatic activities of overexpressed herpes simplex virus DNA polymerase purified from recombinant baculovirus-infected insect cellsA I Marcy, P D Olivo, M D Challberg, et al.
Journal of Virology|October 6, 1997
Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelityY T Hwang, B Y Liu, D M Coen, et al.
The Journal of Biological Chemistry|February 10, 1979
Location of the single gene for the large subunit of ribulosebisphosphate carboxylase on the maize chloroplast chromosomeJ R Bedbrook, D M Coen, A R Beaton, et al.
The Journal of Biological Chemistry|September 9, 1994
Structural and functional organization of herpes simplex virus DNA polymerase investigated by limited proteolysisK Weisshart, A A Kuo, C B Hwang, et al.
Journal of Neurosurgery|October 1, 1992
Expanded spectrum of viral therapy in the treatment of nervous system tumorsJ M Markert, D M Coen, A Malick, et al.
Journal of Virology|December 1, 1981
Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activitiesP A Furman, D M Coen, M H St Clair, et al.
Molecular and Cellular Biology|September 1, 1995
Induction of transcription by a viral regulatory protein depends on the relative strengths of functional TATA boxesW J Cook, B Gu, N A DeLuca, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)G B Mulamba, A Hu, R F Azad, et al.
Science (New York, N.Y.)|May 10, 1991
Experimental therapy of human glioma by means of a genetically engineered virus mutantR L Martuza, A Malick, J M Markert, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Investigative Dermatology|July 1, 1984
Genetics of herpes simplex virusP A Schaffer, S K Weller, B A Pancake, et al.
Nucleic Acids Research|March 11, 1990
Enzymatic activities of overexpressed herpes simplex virus DNA polymerase purified from recombinant baculovirus-infected insect cellsA I Marcy, P D Olivo, M D Challberg, et al.
Journal of Virology|October 6, 1997
Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelityY T Hwang, B Y Liu, D M Coen, et al.
The Journal of Biological Chemistry|February 10, 1979
Location of the single gene for the large subunit of ribulosebisphosphate carboxylase on the maize chloroplast chromosomeJ R Bedbrook, D M Coen, A R Beaton, et al.
The Journal of Biological Chemistry|September 9, 1994
Structural and functional organization of herpes simplex virus DNA polymerase investigated by limited proteolysisK Weisshart, A A Kuo, C B Hwang, et al.
Journal of Neurosurgery|October 1, 1992
Expanded spectrum of viral therapy in the treatment of nervous system tumorsJ M Markert, D M Coen, A Malick, et al.
Journal of Virology|December 1, 1981
Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activitiesP A Furman, D M Coen, M H St Clair, et al.
Molecular and Cellular Biology|September 1, 1995
Induction of transcription by a viral regulatory protein depends on the relative strengths of functional TATA boxesW J Cook, B Gu, N A DeLuca, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)G B Mulamba, A Hu, R F Azad, et al.
Science (New York, N.Y.)|May 10, 1991
Experimental therapy of human glioma by means of a genetically engineered virus mutantR L Martuza, A Malick, J M Markert, et al.
Pageof 12